UBS Group’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,270
| Closed | -$11K | – | 9955 |
|
|
2021
Q3 | $11K | Buy |
2,270
+685
| +43% | +$3.32K | ﹤0.01% | 6822 |
|
|
2021
Q2 | $9K | Sell |
1,585
-1,361
| -46% | -$7.73K | ﹤0.01% | 7098 |
|
|
2021
Q1 | $14K | Sell |
2,946
-736
| -20% | -$3.5K | ﹤0.01% | 6683 |
|
|
2020
Q4 | $16K | Buy |
3,682
+3,674
| +45,925% | +$16K | ﹤0.01% | 6121 |
|
|
2020
Q3 | $0 | Sell |
8
-857
| -99% | – | ﹤0.01% | 7598 |
|
|
2020
Q2 | $2K | Sell |
865
-13,695
| -94% | -$31.7K | ﹤0.01% | 6842 |
|
|
2020
Q1 | $43K | Sell |
14,560
-16,899
| -54% | -$49.9K | ﹤0.01% | 5072 |
|
|
2019
Q4 | $119K | Buy |
31,459
+17,638
| +128% | +$66.7K | ﹤0.01% | 4888 |
|
|
2019
Q3 | $70K | Buy |
13,821
+12,956
| +1,498% | +$65.6K | ﹤0.01% | 5063 |
|
|
2019
Q2 | $5K | Sell |
865
-181
| -17% | -$1.05K | ﹤0.01% | 6533 |
|
|
2019
Q1 | $7K | Sell |
1,046
-3,148
| -75% | -$21.1K | ﹤0.01% | 6202 |
|
|
2018
Q4 | $35K | Buy |
4,194
+729
| +21% | +$6.08K | ﹤0.01% | 5466 |
|
|
2018
Q3 | $69K | Hold |
3,465
| – | – | ﹤0.01% | 5026 |
|
|
2018
Q2 | $90K | Sell |
3,465
-191,038
| -98% | -$4.96M | ﹤0.01% | 4638 |
|
|
2018
Q1 | $4.65M | Buy |
194,503
+155,559
| +399% | +$3.72M | ﹤0.01% | 1914 |
|
|
2017
Q4 | $1.32M | Buy |
38,944
+10,377
| +36% | +$352K | ﹤0.01% | 2814 |
|
|
2017
Q3 | $605K | Buy |
+28,567
| New | +$605K | ﹤0.01% | 3331 |
|
|
2017
Q1 | – | Sell |
-1,536
| Closed | -$26K | – | 6925 |
|
|
2016
Q4 | $26K | Sell |
1,536
-353
| -19% | -$5.98K | ﹤0.01% | 5412 |
|
|
2016
Q3 | $31K | Buy |
+1,889
| New | +$31K | ﹤0.01% | 5030 |
|
|
2016
Q1 | – | Sell |
-1,891
| Closed | -$54K | – | 6968 |
|
|
2015
Q4 | $54K | Buy |
1,891
+894
| +90% | +$25.5K | ﹤0.01% | 4692 |
|
|
2015
Q3 | $17K | Buy |
997
+598
| +150% | +$10.2K | ﹤0.01% | 5587 |
|
|
2015
Q2 | $10K | Sell |
399
-449
| -53% | -$11.3K | ﹤0.01% | 5988 |
|
|
2015
Q1 | $15K | Buy |
848
+258
| +44% | +$4.56K | ﹤0.01% | 5621 |
|
|
2014
Q4 | $10K | Buy |
+590
| New | +$10K | ﹤0.01% | 6010 |
|